期刊文献+

罗格列酮钠对2型糖尿病患者糖脂代谢的影响 被引量:1

下载PDF
导出
摘要 【目的】观察罗格列酮钠对2型糖尿病患者糖脂代谢的影响。【方法】对新发2型糖尿病患者及已经磺脲类和双瓜类治疗效果不佳的患者加用罗格列酮钠治疗12周,分别检测治疗前后的血糖血脂变化,进行观察比对。【结果】用罗格列酮钠治疗后,空腹血糖(FBG)、餐后2小时血糖(2hPBG)、糖化血红蛋白(HbA-IC)、血甘油三酯(TG)均有明显降低(P<0.05)。【结论】罗格列酮钠具有较好的降血糖和甘油三酯的作用,且经济安全。
作者 陈昕 葛文新
出处 《医学临床研究》 CAS 2008年第1期147-148,共2页 Journal of Clinical Research
  • 相关文献

参考文献3

二级参考文献17

  • 1唐孝誌.瑞格列奈治疗2型糖尿病患者的临床疗效观察[J].医学临床研究,2005,22(1):110-112. 被引量:1
  • 2杨刚毅,邱鸿鑫,邓华聪,李伶,汪恕萍,张素华.NIDDM 患者血浆游离脂肪酸含量及其与体重指数的关系[J].中国糖尿病杂志,1997,5(2):115-116. 被引量:10
  • 3傅宏义 周筱青 郭代红.新编医院药物大全[M].北京:中国医药科技出版社,2003.739.
  • 4Philip Raskin.A randomized trial of roaiglitarone therapy in patients with inadequately controled insulin-treated type 2 diabetes[J].Diabetes Care,2001,24(7):1226-1233.
  • 5Stefano DP,Antonio T.The importance of firstphase insulin secretion:implications of therapy of type 2 diabetes mellitus[J].Diabetes Metab Res Rev,2001,17:164-174.
  • 6Malaisse WJ.Stimulation of insulin release by non-sulfonylurea hypoglycem ic agents:the meglitinide family[J].Horm one Metab Res,1995,27:263-266.
  • 7Schmitz O,Lund S,Andersen PH,et al.Optimizing insulin secretagogue therapy in patients with type 2 diabetes a ran domized double-blind study with repaglinide[J].Diabetes Care,2002,25:342-346.
  • 8Smith S,Boam D,Bretherton Watt D,et al.Rosiglitazone increases pan creatic islet area,density and insulin content,butn or insulin gene expression[J].Diabetes,1998,47(supplement 1):A18(Abstract0072):92-93.
  • 9Cederholm J ,Wiebell L. Insulin release and peripheral sensitivity at the oral glucose test[J].Diab Res Clin Pract,1990,10(2):167-175.
  • 10Haffner SM,Miettinen H,Gaskill SP,et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-day risk of NIDDM in Mexican-Americans[J].Diabetes,1995,44(12):1386-1391.

共引文献8

同被引文献7

  • 1Imanishi T, Kobayashi K, Kuroi A, et al . Pioglitazone inhibits angiotensin Ⅱ-induced senescence of endothelial progenitor cell[J]. Hypertens Res , 2008,31(4) :757-765.
  • 2Ruiz E, Redondo S, Gordillo-Moscoso A, et al . Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway 1[J]. J Pharmacol Exp Ther ,2007,321(2):431-438.
  • 3Kato MF, Shibata R, Obata K, et al . Pioglitazone attenuates cardiac hypertrophy in rats with salt sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt[J]. J Hypertens ,2008,26(8) : 1669-1676.
  • 4Boyle PJ. Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records[J]. Clin Ther ,2002,24(3):378-396.
  • 5Kawakami S, Arai G, Hayashi T, et al . PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro [J]. J Cell Physiol , 2002 , 191(3):310-319.
  • 6Rumi MA. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands[J]. J Lab Clin Med , 2002 ,140(1) :17-26.
  • 7高利群.辛伐他汀与匹格列酮对2型糖尿病血管内皮功能的影响[J].医学临床研究,2007,24(6):1016-1017. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部